Brief Videos Delivered by Text Messages as a Public Health Intervention for PTSD in Youth

September 3, 2025 updated by: Patrick J. McGrath, IWK Health Centre

Brief Videos Delivered by Text Messages as a Public Health Intervention for PTSD in Youth: A Feasibility and Acceptability Randomized Trial

The goal of this clinical trial is to learn if informational videos (the intervention) sent by text messages can help young people (age 15 - 25) manage symptoms of post traumatic stress disorder (PTSD). This is a small-scale trial to evaluate whether the intervention has potential to be effective, whether it is feasible to carry out a bigger study, and whether youth find the intervention acceptable.The main questions it aims to answer are:

  1. Does the intervention help youth reduce their symptoms of PTSD, anxiety, and depression, improve how well they function day-to-day, and lead to post-traumatic growth.
  2. Will it be possible to conduct a larger study on the intervention (e.g., are we able to attract participants to take part in the study; do participants follow through with the intervention and the study) and is the intervention acceptable to youth (e.g., do they watch the videos, and rate the videos as useful, interesting, understandable, and relevant)?

Researchers will compare those who receive the intervention right away to those who wait to receive the intervention to see if there are differences between groups.

Videos will teach youth about PTSD and provide the opportunity to practice strategies that have been shown to help with reduce symptoms of PTSD, such as exposure, reducing avoidance, social support, and coping strategies (e.g., changing your thoughts, deep breathing, and muscle relaxation).

The study is fully online. Participants will be randomly placed in one of two groups:

  1. Intervention Group: Gets three PTSD-related text messages per week for 10 weeks. They will also be asked to rate each of the videos on how helpful you found them.
  2. Waitlist Group: Does not receive text messages until AFTER the final surveys for the study are completed (i.e., 5 months), then will receive the intervention.

Everyone will be asked to complete online surveys about their mental health and functioning 3 times during the study:

  • Beginning of the study
  • 10 weeks into the study
  • 3 months after the videos end (end of study)

Study Overview

Study Type

Interventional

Enrollment (Estimated)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Likely diagnosis of PTSD as indicated by a minimum score of 31 on the Post Traumatic Stress Disorder Checklist
  • Direct exposure to actual or threatened death, serious injury, or sexual violence or through witnessing, learning it happened to a close relation as assessed by the Life Events Checklist
  • Between 15 and 25 years old at time of enrolment
  • Access to a mobile phone and a data plan that allows them to receive text messages and videos
  • Live in Canada

Exclusion Criteria:

  • Presence of active suicidality, determined by items from the Patient Safety Screener
  • Active symptoms of psychosis, indicated by a brief Psychosis Screener Questionnaire
  • An inability to read and/or understand English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Brief Video Intervention
Participants will receive three text messages per week for 10 weeks. Each message contains a link to a video providing information about PTSD and coping strategies.

The intervention consists of brief videos delivered by text message, designed to deliver psychoeducation, coping strategies, and social support guidance for youth with PTSD. The focus is to reduce avoidance behaviors, increase exposure, change cognitions and enhance social support.

The text messages will follow a six-module curriculum, covering key PTSD recovery topics:

  1. Psychoeducation on PTSD - Understanding symptoms, trauma responses, and brain plasticity.
  2. Reducing Avoidance - Encouraging gradual engagement with feared thoughts and situations.
  3. Cognitive Coping Strategies - Introducing cognitive restructuring techniques.
  4. Behavioral Coping Strategies - Teaching relaxation techniques (e.g., deep breathing, grounding).
  5. Social Support - Highlighting the role of social support and strategies to strengthen connections.
  6. Maintenance and Relapse Prevention - Preparing for setbacks and reinforcing progress.
No Intervention: Control Group
The control group will receive no intervention. They will have access to the intervention after they complete all study activities, however they will not be included in the data analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Posttraumatic Stress as Assessed by the PTSD Checklist (PCL-5) at 10 Weeks (End of Treatment)
Time Frame: From enrolment to the end of treatment at 10 weeks
The PCL-5 is a 20-item self-report measure assessing PTSD symptom severity based on Diagnostic Statistical Manual of Mental Disorders (DSM-5) criteria. Participants rate how much symptoms have bothered them in the past month on a scale from 0 (not at all) to 4 (extremely). Symptom scores range from 0 to 80, with higher scores indicating more severe symptoms. A score of 31 or higher indicates a probable diagnosis of PTSD.
From enrolment to the end of treatment at 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Posttraumatic Stress as Assessed by the PTSD Checklist (PCL-5) at 3 Months After Treatment
Time Frame: 3 Months After Treatment (22 weeks after enrolment)
The PCL-5 is a 20-item self-report measure assessing PTSD symptom severity based on Diagnostic Statistical Manual of Mental Disorders (DSM-5) criteria. Participants rate how much symptoms have bothered them in the past month on a scale from 0 (not at all) to 4 (extremely). Symptom scores range from 0 to 80, with higher scores indicating more severe symptoms. A score of 31 or higher indicates a probable diagnosis of PTSD.
3 Months After Treatment (22 weeks after enrolment)
Change in Anxiety Score as Measured by the Generalized Anxiety Disorder-7 (GAD-7) at 10 Weeks After Enrolment (Post-Treatment) and 3 Months After Treatment
Time Frame: From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
The GAD-7 is a 7-item measure assessing generalized anxiety symptoms. Higher scores indicate greater anxiety severity.
From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
Change in Depression Score as Measured by the Patient Health Questionnaire-9 (PHQ-9) at 10 Weeks After Enrolment (Post-Treatment) and 3 Months After Treatment
Time Frame: From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
The PHQ-9 is a 9-item measure assessing depression symptoms. Higher scores indicate greater depression severity.
From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
Change in Functional Impairment Scores as Measured by the Sheehan Disability Scale (SDS) at 10 Weeks After Enrolment (Post-Treatment) and 3 Months After Treatment.
Time Frame: From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
The SDS will assess the severity of functional impairment. Higher scores indicate more impairment.
From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
Change in Posttraumatic Growth as Measured by The Posttraumatic Growth Inventory - Short Form (PTGI-SF) at 10 Weeks After Enrolment and 3 Months After Treatment
Time Frame: From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.
The PTGI-SF is a 10-item measure assessing positive psychological changes following trauma.
From enrolment to the end of treatment at 10 weeks and 3 months after treatment ends.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility and Acceptability as Measured by Engagement and Video Ratings
Time Frame: From enrolment to end of treatment (10 weeks)
The feasibility and acceptability of the text message-based intervention will be assessed throughout the study using recruitment and retention rates (i.e., number of participants enrolled and completing follow-ups), message engagement (i.e., number of messages rated by participants), and participant satisfaction (i.e., ratings of message helpfulness, relevance, and supportiveness). After each text, participants will be asked to rate how useful, relevant, interesting, and understandable they found the messages on a scale of 0 (not at all) to 4 (extremely).
From enrolment to end of treatment (10 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrick J McGrath, PhD, IWK Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 10, 2025

Primary Completion (Estimated)

September 10, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

September 3, 2025

First Submitted That Met QC Criteria

September 3, 2025

First Posted (Estimated)

September 10, 2025

Study Record Updates

Last Update Posted (Estimated)

September 10, 2025

Last Update Submitted That Met QC Criteria

September 3, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 1031707
  • FDN148371 (Other Grant/Funding Number: Canadian Institutes of Health Research (CIHR))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

During the informed consent process, study participants are invited to provide consent for their de-identified study data to be shared with other researchers only with the consent of the study participants. Data from those who consent may be shared with researchers provided they have ethics board approval. All participant data except for identifying data may be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Traumatic Stress Disorder in Adolescence

Clinical Trials on Brief Videos Delivered by Text Message

3
Subscribe